Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield S10 2HQ, UK.
Institute of Public Health, University of Cambridge, Cambridge CB2 0SR, UK.
Int J Mol Sci. 2020 Oct 25;21(21):7924. doi: 10.3390/ijms21217924.
White matter lesions (WML) are a common feature of the ageing brain associated with cognitive impairment. The gene expression profiles of periventricular lesions (PVL, = 7) and radiologically-normal-appearing (control) periventricular white matter cases ( = 11) obtained from the Cognitive Function and Ageing Study (CFAS) neuropathology cohort were interrogated using microarray analysis and NanoString to identify novel mechanisms potentially underlying their formation. Histological characterisation of control white matter cases identified a subgroup ( = 4) which contained high levels of MHC-II immunoreactive microglia, and were classified as "pre-lesional." Microarray analysis identified 2256 significantly differentially-expressed genes ( ≤ 0.05, FC ≥ 1.2) in PVL compared to non-lesional control white matter (1378 upregulated and 878 downregulated); 2649 significantly differentially-expressed genes in "pre-lesional" cases compared to PVL (1390 upregulated and 1259 downregulated); and 2398 significantly differentially-expressed genes in "pre-lesional" versus non-lesional control cases (1527 upregulated and 871 downregulated). Whilst histological evaluation of a single marker (MHC-II) implicates immune-activated microglia in lesion pathology, transcriptomic analysis indicates significant downregulation of a number of activated microglial markers and suggests established PVL are part of a continuous spectrum of white matter injury. The gene expression profile of "pre-lesional" periventricular white matter suggests upregulation of several signalling pathways may be a neuroprotective response to prevent the pathogenesis of PVL.
脑白质病变(WML)是与认知障碍相关的老年脑的常见特征。使用微阵列分析和 NanoString 分析从认知功能和衰老研究(CFAS)神经病理学队列中获得的脑室周围病变(PVL, = 7)和放射学正常表现(对照)脑室周围白质病例( = 11)的基因表达谱,以鉴定潜在形成的新机制。对照白质病例的组织学特征确定了一个亚组( = 4),其中包含高水平的 MHC-II 免疫反应性小胶质细胞,被归类为“前病变”。微阵列分析鉴定了与非病变对照白质相比,PVL 中显著差异表达的 2256 个基因( ≤ 0.05,FC ≥ 1.2)(1378 个上调和 878 个下调);与 PVL 相比,“前病变”病例中显著差异表达的 2649 个基因(1390 个上调和 1259 个下调);与非病变对照病例相比,“前病变”病例中显著差异表达的 2398 个基因(1527 个上调和 871 个下调)。虽然单个标志物(MHC-II)的组织学评估表明免疫激活的小胶质细胞与病变病理学有关,但转录组分析表明许多激活的小胶质细胞标志物的表达显著下调,并表明已建立的 PVL 是白质损伤连续谱的一部分。“前病变”脑室周围白质的基因表达谱表明,几个信号通路的上调可能是一种神经保护反应,以防止 PVL 的发病机制。